Bone marrow transplant - BMT for CML

''Hematopoietic stem cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood.[1][2][3] It may be autologous (the patient's own stem cells are used), allogeneic (the stem cells come from a donor) or syngeneic (from an identical twin).[1][2]
It is most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia.[2] In these cases, the recipient's immune system is usually destroyed with radiation or chemotherapy before the transplantation. Infection and graft-versus-host disease are major complications of allogeneic HSCT.[2]
Hematopoietic stem cell transplantation remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases. As survival following the procedure has increased, its use has expanded beyond cancer to autoimmune diseases[4][5] and hereditary skeletal dysplasias; notably malignant infantile osteopetrosis[6][7] and mucopolysaccharidosis.[8] ''
Extract of wikipedia
ARTICLES

InsightRX’s Precision Medicine Technology to Help Improve Care for Patients Receiving Stem Cell Transplants
November 22, 2021, Bio-ITWorld

Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia
March 25, 2020, Cancer Connect

10-Year OS After Bone Marrow Transplantation for CML Similar With/Without Prior TKI Therapy
August 16, 2019, Oncology Nurse Advisor
​
Allogenic Stem Cell transplantation for CML in the TKI era: population based data from the Swedish CML registry
June 15, 2018, EHA learning center
 
Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experience
February 6, 2017, World Journal of Hematology

Long-Term Mortality High After CML Transplant
December 6, 2016, MedpageToday
​
Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors
August 2015, Biology of Blood and Marrow Transplantation

New therapy for bone-marrow transplant gives hope to patients over 55
February 3, 2014 , Physicians NewsDigest
             
Researchers Aim to Improve Blood Cancer Outcomes With Engineered T-Cell Treatments
January 2, 2014, OncLive

Age No Longer Should be a Barrier to Stem Cell Transplantation for Older Patients with Blood Cancers
November 1, 2011, NewsWise

Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program
February 2010, Biology of Blood and Marrow Transplantation

Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter?
January 2006, PubMed

Transplantation for chronic myelogenous leukemia:yes, no, maybe soyan Oregon perspective
2003, PubMed
​
Surviving Leukemia: A Practical Guide by Dr. Robert Patenaude
1999, Firefly Book      
​
                                         Modes of access to the website
​
1 - Public access  (strongly recommended)
     On several occasions, the CML patient called CMLer will need a password  to access several modules of the website.  
                  (No registration required - Anonymous access)​
​2 - Reserved access to CMLeukemia private group
     On other occasions, the more experienced patients will need more up-to-date or in-depth information. Among other upcoming modules, they will need access to the archives and also to abstracts of congresses on CML.
​                  (Member password required and registration required).